Type 2 diabetes and obesity references
Authors in bold are Jackson Laboratory scientists
Silveira PA, Dombrowsky J, Johnson E, Chapman HD, Nemazee D, Serreze DV. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol 2004; 172:5086-5094.
Leiter EH, Reifsnyder PC. Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Diabetes 2004 Feb; 53(S1):S4-S11.
Serreze DV, Pierce MA, Post CM, Chapman HD, Savage H, Bronson RT, Rothman PB, Cox GA. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene. J Immunol. 2003 Mar 1;170(5):2742-9.
Kim JH, Taylor PN, Young D, Karst SY, Nishina PM, Naggert JK. New Leptin Receptor Mutations in Mice: Lepr(db-rtnd), Lepr(db-dmpg) and Lepr(db-rlpy). J Nutr. 2003 May;133(5):1265-71.
Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV. Contribution
of Fas to diabetes development. Proc Natl Acad Sci USA 2003; 100(2):628-632.
Haskell BD, Flurkey K, Duffy TM, Sargent EE, Leiter EH. The diabetes-prone NZO/HILt strain. I. Immunophenotypic comparison to the related NZB/BINJ and NZW/LacJ strains. Lab Invest 2002; 82:833-842.
Leiter EH. Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 2002; 45:296-308.
